Collapsing Companies: Regado Biosciences Inc(NASDAQ:RGDO), Rentech, Inc.(NASDAQ:RTK), and Ampio Pharmaceuticals Inc(NYSEMKT:AMPE)

Posted by admin September 11, 2014 0 Comment 1666 views


New York, NY – 09/11/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

Regado Biosciences Inc(NASDAQ:RGDO) lost five cents as the stock fell to a new closing price of $1.13 yesterday, a 4.24% loss in value from the previous closing price. The stock has traded within a range of $1.01 to $14.10 over the past 52 weeks. Regado Biosciences Inc(NASDAQ:RGDO) is currently facing a class action lawsuit for allegedly violating federal securities laws. The company currently has a bid price of $1.12 x 2,800 and an offer price of $1.20 x 100.

Will Regado Biosciences Recover? View Our Free RGDO Analysis.

Rentech, Inc.(NASDAQ:RTK) fell seven cents yesterday, a 3.27% loss in value that places the stock at a new closing price of $2.07. The stock traded within a range of $2.06 to $2.14 during the day after opening at a price of $2.12. Rentech, Inc.(NASDAQ:RTK) will be attending the Imperial Capital Global Opportunities Conference in New York City on Sept. 18th, 2014. The company had a trading volume of 1,785,439 yesterday, a figure which is 586,081 below its three month average of 2,371,520.

Can Rentech Rebound? Click Here For A Free RTK Analysis.

Ampio Pharmaceuticals Inc(NYSEMKT:AMPE) saw its value decline by 1.4% yesterday as the stock lost five cents to move to a new closing price of $3.52. The stock also traded for as little as $3.43 during the day, a new 52 week low for the Colorado-based development stage company. Recently, the products of Ampio Pharmacueticals Inc(NYSEMKT:AMPE) have received some criticism from the media. TheStreet recently opined that the company’s knee arthritis drug is just about as effective as a placebo.

Is Ampio’s Recent Criticism Valid? Receive A Free AMPE Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment